eMedicine Specialties > Pediatrics: Cardiac Disease and Critical Care Medicine > Neonatology

Neonatal Hypertension: Differential Diagnoses & Workup

Author: Joseph Flynn, MD, MS, Director of Pediatric Hypertension Program, Division of Nephrology, Children's Hospital and Regional Medical Center; Professor, Department of Pediatrics, University of Washington School of Medicine
Contributor Information and Disclosures

Updated: Dec 4, 2008

Differential Diagnoses

Acute Tubular Necrosis
Neonatal Hypertension
Bronchopulmonary Dysplasia
Neuroblastoma
Coarctation of the Aorta
Noonan Syndrome
Extremely Low Birth Weight Infant
Polycystic Kidney Disease
Fluid, Electrolyte, and Nutrition Management of the Newborn
Posterior Urethral Valves
Follow-up of the NICU Patient
Prematurity
Graves Disease
Renal Cortical Necrosis
Hematuria
Respiratory Distress Syndrome
Hyperaldosteronism
Thromboembolism
Hypercalcemia
Tuberous Sclerosis
Hypertension
Turner Syndrome
Hyperthyroidism
Ureteropelvic Junction Obstruction
Infantile Polyarteritis Nodosa
Williams Syndrome
Multicystic Renal Dysplasia
Wilms Tumor

Other Problems to Be Considered

Renovascular conditions

Thromboembolism
Renal artery stenosis
Midabdominal aortic coarctation
Renal venous thrombosis
Compression of renal artery
Idiopathic arterial calcification
Congenital rubella syndrome

Renal parenchymal disease

Polycystic kidney disease
Multicystic-dysplastic kidney disease
Tuberous sclerosis
Ureteropelvic junction obstruction
Acute tubular necrosis
Cortical necrosis
Interstitial nephritis
Hemolytic-uremic syndrome

Pulmonary conditions

Bronchopulmonary dysplasia (BPD)
Pneumothorax

Cardiac conditions

Thoracic aortic coarctation

Endocrine conditions

Congenital adrenal hyperplasia
Hyperaldosteronism
Hyperthyroidism
Pseudohypoaldosteronism type II

Medications/Intoxications

Dexamethasone
Adrenergic agents
Vitamin D intoxication
Theophylline
Caffeine
Pancuronium
Phenylephrine
Maternal cocaine or heroin use

Tumors

Neoplasia
Wilms tumor
Mesoblastic nephroma
Neuroblastoma
Pheochromocytoma

Neurologic conditions

Pain
Intracranial hypertension
Seizures
Familial dysautonomia
Subdural hematoma

Miscellaneous conditions

Closure of abdominal wall defect
Adrenal hemorrhage
Hypercalcemia
Traction
Extracorporeal membrane oxygenation (ECMO)
Birth asphyxia
Urological neoplasms

Workup

Laboratory Studies

  • Usually only a limited set of laboratory data are needed in the evaluation of neonatal hypertension. Obtain serum electrolyte, creatinine, and BUN levels as well as urinalysis in order to look for renal parenchymal disease. Obtain endocrinologic studies, such as cortisol, aldosterone, or thyroxine, when pertinent history is noted.
  • Measurement of plasma renin activity (PRA) is usually recommended as part of the laboratory assessment in newborns with hypertension, although elevated peripheral renin levels may not signify the presence of underlying pathology because renin values are typically high in infancy. In addition, plasma renin levels may be falsely elevated by medications that are commonly used in the neonatal ICU (NICU), such as aminophylline. Furthermore, many laboratories have switched from measurement of PRA to the direct renin assay, which is easier to perform. However, normative values for the direct renin assay in neonates are not widely available. Keep these factors in mind when interpreting renin values.
  • Alternatively, suppressed PRA in an infant with hypertension is a significant finding, possibly indicating the presence of a genetic form of hypertension associated with volume overload, such as glucocorticoid-remediable aldosteronism or Liddle Syndrome.

Imaging Studies

  • Chest radiography may be helpful in infants with congestive heart failure (CHF) or in those with a murmur upon physical examination.
  • Perform renal ultrasonography with Doppler of the renal vessels in all hypertensive infants. Accurate renal ultrasonography may help uncover potentially correctable causes of hypertension (eg, renal venous thrombosis [RVT]); it may detect aortic thrombi, renal arterial thrombi, or both; and it can reveal anatomic renal abnormalities or other congenital renal parenchymal disease. Ultrasonography is fast, noninvasive, and relatively inexpensive. Ultrasonography has largely replaced intravenous pyelography, which has little, if any, use in the routine assessment of neonatal hypertension.
  • For infants with extremely severe blood pressure (BP) elevation, angiography may be necessary. Although some investigators have used aortography via the umbilical artery catheter, formal renal arteriography using the traditional femoral vascular approach is much more accurate for diagnosing renal arterial stenosis, primarily because of the high incidence of intrarenal branch vessel abnormalities observed in children with fibromuscular dysplasia (FMD). Depending on the expertise available, this may need to be deferred until the infant is larger. MR and CT angiography are of little value in infants as they do not provide sufficient resolution to identify branch vessel stenoses.
  • Nuclear scanning may demonstrate abnormalities of renal perfusion caused by thromboembolic phenomenon, although obtaining good studies in infants is difficult because of their immature renal function.
  • Obtain other studies, including echocardiography and voiding cystourethrography, as indicated.

More on Neonatal Hypertension

Overview: Neonatal Hypertension
Differential Diagnoses & Workup: Neonatal Hypertension
Treatment & Medication: Neonatal Hypertension
Follow-up: Neonatal Hypertension
References

References

  1. Seliem WA, Falk MC, Shadbolt B, Kent AL. Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up. Pediatr Nephrol. Dec 2007;22(12):2081-7. [Medline].

  2. Friedman AL, Hustead VA. Hypertension in babies following discharge from a neonatal intensive care unit. A 3-year follow-up. Pediatr Nephrol. Jan 1987;1(1):30-4. [Medline].

  3. Zubrow AB, Hulman S, Kushner H, Falkner B. Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. Philadelphia Neonatal Blood Pressure Study Group. J Perinatol. Nov-Dec 1995;15(6):470-9. [Medline].

  4. Task Force on Blood Pressure Control in Children. Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics. Jan 1987;79(1):1-25. [Medline].

  5. Singh HP, Hurley RM, Myers TF. Neonatal hypertension. Incidence and risk factors. Am J Hypertens. Feb 1992;5(2):51-5. [Medline].

  6. Neal WA, Reynolds JW, Jarvis CW, Williams HJ. Umbilical artery catheterization: demonstration of arterial thrombosis by aortography. Pediatrics. Jul 1972;50(1):6-13. [Medline].

  7. Abman SH, Warady BA, Lum GM, Koops BL. Systemic hypertension in infants with bronchopulmonary dysplasia. J Pediatr. Jun 1984;104(6):928-31. [Medline].

  8. Alagappan A, Malloy MH. Systemic hypertension in very low-birth weight infants with bronchopulmonary dysplasia: incidence and risk factors. Am J Perinatol. Jan 1998;15(1):3-8. [Medline].

  9. Flynn JT. Neonatal hypertension: diagnosis and management. Pediatr Nephrol. Apr 2000;14(4):332-41. [Medline].

  10. Adelman RD. Long-term follow-up of neonatal renovascular hypertension. Pediatr Nephrol. Jan 1987;1(1):35-41. [Medline].

  11. Boedy RF, Goldberg AK, Howell CG Jr, et al. Incidence of hypertension in infants on extracorporeal membrane oxygenation. J Pediatr Surg. Feb 1990;25(2):258-61. [Medline].

  12. Crapanzano MS, Strong WB, Newman IR, et al. Calf blood pressure: clinical implications and correlations with arm blood pressure in infants and young children. Pediatrics. Feb 1996;97(2):220-4. [Medline].

  13. Crossland DS, Furness JC, Abu-Harb M, et al. Variability of four limb blood pressure in normal neonates. Arch Dis Child Fetal Neonatal Ed. Jul 2004;89(4):F325-7. [Medline].

  14. de Swiet M, Fayers P, Shinebourne EA. Systolic blood pressure in a population of infants in the first year of life: the Brompton study. Pediatrics. May 1980;65(5):1028-35. [Medline].

  15. Duley L. Pre-eclampsia and the hypertensive disorders of pregnancy. Br Med Bull. 2003;67(1):161-76. [Medline].

  16. Elliot SJ, Hansen TN. Neonatal hypertension. In: Long WA, ed. Fetal and Neonatal Cardiology. Philadelphia, PA: WB Saunders Co; 1990:492-8.

  17. Flynn JT, Smoyer WE, Bunchman TE. Treatment of hypertensive children with amlodipine. Am J Hypertens. Oct 2000;13(10):1061-6. [Medline].

  18. Flynn JT, Warnick SJ. Isradipine treatment of hypertension in children: a single-center experience. Pediatric Nephrology. 2002;17:748-53. [Medline].

  19. Gouyon JB, Geneste B, Semama DS, et al. Intravenous nicardipine in hypertensive preterm infants. Arch Dis Child Fetal Neonatal Ed. Mar 1997;76(2):F126-7. [Medline].

  20. Inglefinger JR. Hypertension in the first year of life. In: Inglefinger JR, ed. Pediatric Hypertension. Philadelphia, PA: WB Saunders Co; 1982:229-40.

  21. Low JA, Panagiotopoulos C, Smith JT, et al. Validity of newborn oscillometric blood pressure. Clin Invest Med. Jun 1995;18(3):163-7. [Medline].

  22. Markham LA, Stevens DL. A case report of neonatal thyrotoxicosis due to maternal autoimmune hyperthyroidism. Adv Neonatal Care. Dec 2003;3(6):272-85. [Medline].

  23. Merten DF, Vogel JM, Adelman RD, et al. Renovascular hypertension as a complication of umbilical arterial catheterization. Radiology. Mar 1978;126(3):751-7. [Medline].

  24. Mocan H, Beattie TJ, Murphy AV. Renal venous thrombosis in infancy: long-term follow-up. Pediatr Nephrol. Jan 1991;5(1):45-9. [Medline].

  25. Nwankwo MU, Lorenz JM, Gardiner JC. A standard protocol for blood pressure measurement in the newborn. Pediatrics. Jun 1997;99(6):E10. [Medline][Full Text].

  26. Roth CG, Spottswood SE, Chan JC, Roth KS. Evaluation of the hypertensive infant: a rational approach to diagnosis. Radiol Clin North Am. Sep 2003;41(5):931-44. [Medline].

  27. Roy S, Dillon MJ, Trompeter RS, Barratt TM. Autosomal recessive polycystic kidney disease: long-term outcome of neonatal survivors [published erratum appears in Pediatr Nephrol 1997 Oct;11(5):664]. Pediatr Nephrol. Jun 1997;11(3):302-6. [Medline].

  28. Sheftel DN, Hustead V, Friedman A. Hypertension screening in the follow-up of premature infants. Pediatrics. May 1983;71(5):763-6. [Medline].

  29. Skalina ME, Kliegman RM, Fanaroff AA. Epidemiology and management of severe symptomatic neonatal hypertension. Am J Perinatol. Jul 1986;3(3):235-9. [Medline].

  30. Smets K, Vanhaesebrouck P. Dexamethasone associated systemic hypertension in low birth weight babies with chronic lung disease. Eur J Pediatr. Jul 1996;155(7):573-5. [Medline].

  31. Susskind MR, Kim KS, King LR. Hypertension and multicystic kidney. Urology. Dec 1989;34(6):362-6. [Medline].

  32. Wells TG, Bunchman TE, Kearns GL. Treatment of neonatal hypertension with enalaprilat. J Pediatr. Oct 1990;117(4):664-7. [Medline].

  33. Yau V, Chow E, Davis L, et al. Pain management in cancer patients with bone metastases remains a challenge. J Pain Symptom Manage. Jan 2004;27(1):1-3. [Medline].

Further Reading

Keywords

neonatal hypertension, high blood pressure, high BP, premature infants, bronchopulmonary dysplasia, BPD, steroids, maternal hypertension, umbilical arterial catheter, postnatal acute renal failure, patent ductus arteriosus, chronic lung disease, congestive heart failure, cardiogenic shock, congenital adrenal hyperplasia, CAH, umbilical artery catheter–associated thromboembolism, renal venous thrombosis, RVT, renal artery stenosis, fibromuscular dysplasia, FMD, rubella, polycystic kidney disease, PKD, hydronephrotic kidney, nephromegaly, multicystic dysplastic kidney, congenital ureteropelvic junction obstruction, ureteral obstruction, hyperaldosteronism, hyperthyroidism, hypercalcemia, neuroblastoma, Wilms tumor, mesoblastic nephroma

Contributor Information and Disclosures

Author

Joseph Flynn, MD, MS, Director of Pediatric Hypertension Program, Division of Nephrology, Children's Hospital and Regional Medical Center; Professor, Department of Pediatrics, University of Washington School of Medicine
Joseph Flynn, MD, MS is a member of the following medical societies: American Academy of Pediatrics, American Heart Association, American Society of Hypertension, American Society of Nephrology, American Society of Pediatric Nephrology, National Kidney Foundation, and Phi Beta Kappa
Disclosure: Novartis Pharmaceuticals Consulting fee Consulting; Pfizer, Inc Consulting fee Review panel membership

Medical Editor

Steven M Donn, MD, Professor of Pediatrics, Director, Neonatal-Perinatal Medicine, Department of Pediatrics, University of Michigan Health System
Steven M Donn, MD is a member of the following medical societies: American Pediatric Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from broker recommendation; Avanir Pharma Stock Investment from broker recommendation

Managing Editor

Arun K Pramanik, MD, MBBS, Professor of Pediatrics, Director of Neonatal Fellowship, Louisiana State University Health Sciences Center
Arun K Pramanik, MD, MBBS is a member of the following medical societies: American Academy of Pediatrics, American Thoracic Society, National Perinatal Association, and Southern Society for Pediatric Research
Disclosure: Nothing to disclose.

CME Editor

Carol L Wagner, MD, Professor of Pediatrics, Medical University of South Carolina
Carol L Wagner, MD is a member of the following medical societies: American Academy of Pediatrics, American Chemical Society, American Medical Women's Association, American Public Health Association, American Society for Bone and Mineral Research, American Society for Clinical Nutrition, Massachusetts Medical Society, National Perinatal Association, and Society for Pediatric Research
Disclosure: Nothing to disclose.

Chief Editor

Ted Rosenkrantz, MD, Professor, Departments of Pediatrics and Obstetrics/Gynecology, Division of Neonatal-Perinatal Medicine, University of Connecticut School of Medicine
Ted Rosenkrantz, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Pediatric Society, Connecticut State Medical Society, Eastern Society for Pediatric Research, and Society for Pediatric Research
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.